Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-04

Clinical Trial Update: Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dietary counseling plus omega-3 supplementation for Generalized Anxiety Disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (fish oil) supplements (omega-3 fatty acids)

Snippet

Sponsor: The Canadian College of Naturopathic Medicine | Conditions: Generalized Anxiety Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-04-04